These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27317273)

  • 21. Pediatric psoriasis and psoriatic arthritis.
    Lewkowicz D; Gottlieb AB
    Dermatol Ther; 2004; 17(5):364-75. PubMed ID: 15379771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
    Duffin KC; Garg A; Armstrong AW; Helliwell P; Mease PJ
    J Rheumatol; 2014 Jun; 41(6):1240-3. PubMed ID: 24882862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic immunomodulation and cutaneous malignancy in rheumatoid arthritis, psoriasis, and psoriatic arthritis.
    Krathen MS; Gottlieb AB; Mease PJ
    J Rheumatol; 2010 Nov; 37(11):2205-15. PubMed ID: 20810498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.
    Chandran V; Maharaj AB
    Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving Toward Precision Medicine in Psoriasis and Psoriatic Arthritis.
    Ritchlin CT; Pennington SR; Reynolds NJ; FitzGerald O
    J Rheumatol Suppl; 2020 Jun; 96():19-24. PubMed ID: 32482763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
    Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
    JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.
    Kivelevitch DN; Menter A
    Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexisting psoriasis,psoriatic arthritis, gout and Dupuytren's contracture.
    Morasiewicz P; Koprowski P; Dragan S
    Ortop Traumatol Rehabil; 2014; 16(4):441-7. PubMed ID: 25404634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality indicators in psoriatic arthritis.
    Kavanaugh A; Ritchlin C; Boehncke WH
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):98-101. PubMed ID: 18021513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monoclonal CD4 antibodies in psoriasis and psoriatic arthritis].
    Müller W
    Z Rheumatol; 1991; 50(5):331. PubMed ID: 1776371
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel approach to utilizing electronic health records for dermatologic research: developing a multi-institutional federated data network for clinical and translational research in psoriasis and psoriatic arthritis.
    Armstrong AW; Reddy SB; Garg A
    Dermatol Online J; 2012 May; 18(5):2. PubMed ID: 22630572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting.
    Garg A; Gladman DD; Mease PJ
    J Rheumatol; 2012 Nov; 39(11):2214-5. PubMed ID: 23118291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary psoriasis and psoriatic arthritis unit: report of 4 years' experience.
    Luelmo J; Gratacós J; Moreno Martínez-Losa M; Ribera M; Romaní J; Calvet J; Leal L; Larrosa M
    Actas Dermosifiliogr; 2014 May; 105(4):371-7. PubMed ID: 24360030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis and Psoriatic Arthritis: Flip Sides of the Coin?
    Boehncke WH
    Acta Derm Venereol; 2016 May; 96(4):436-41. PubMed ID: 26928459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
    Szentpetery A; Johnson MA; Ritchlin CT
    J Rheumatol; 2014 Jun; 41(6):1200-5. PubMed ID: 24882852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
    Villacorta R; Hay JW; Messali A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of psoriatic arthritis: management recommendations.
    Gossec L; Smolen JS
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S73-7. PubMed ID: 26471459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexisting gout, erythrodermic psoriasis and psoriatic arthritis.
    Liu M; Li JH; Li B; He CD; Xiao T; Chen HD
    Eur J Dermatol; 2009; 19(2):184-5. PubMed ID: 19106055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.